Thrombocytosis and coronary occlusion.
Department of Cardiology, Lehigh Valley Health Network, Allentown, Pennsylvania 18103, USA. amit_n.nanavati@lvh.com
Amit
A
Nanavati
Nainesh
N
Patel
James
J
Burke
D000328:Adult; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation; D002317:Cardiovascular Agents / Q000008:administration & dosage; D017023:Coronary Angiography; D054059:Coronary Occlusion / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy; D003328:Coronary Thrombosis / Q000000981:diagnostic imaging / Q000209:etiology* / Q000628:therapy; D054855:Drug-Eluting Stents; D000068338:Everolimus; D006801:Humans; D053614:Janus Kinase 2 / Q000235:genetics; D008297:Male; D009154:Mutation; D009203:Myocardial Infarction / Q000209:etiology / Q000628:therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D010976:Platelet Count; D020123:Sirolimus / Q000008:administration & dosage / Q000031:analogs & derivatives; D017131:Thrombectomy; D013922:Thrombocytosis / Q000097:blood / Q000150:complications* / Q000201:enzymology / Q000235:genetics; D016896:Treatment Outcome
D002317:Cardiovascular Agents; D010975:Platelet Aggregation Inhibitors; D000068338:Everolimus; C507924:JAK2 protein, human; D053614:Janus Kinase 2; D020123:Sirolimus